Literature DB >> 15186343

Therapy for neurobehavioral disorders in epilepsy.

Orrin Devinsky1.   

Abstract

Neurobehavioral disorders commonly affect patients with epilepsy. In addition to the behavioral changes during and immediately after seizures, the epileptogenic disorder of function often extends further into the postictal and interictal period. Cognitive impairments commonly affect attention, memory, mental speed, and language, as well as executive and social functions. Reducing seizure frequency and the antiepileptic drug burden can reduce these problems. Attentional deficits may respond to therapies for attention-deficit/hyperactivity disorder, but apart from patients with this comorbid disorder, their efficacy is unproven in other epilepsy patients. No effective therapies are established for other cognitive problems, but pragmatic, compensatory strategies can be helpful. Behavioral disorders include fatigue, depression, anxiety, and psychosis. Many of these disorders usually respond well to pharmacotherapy, which can be supplemented by psychotherapy. Cognitive and behavioral disorders can be the greatest cause of morbidity and impaired quality of life, often overshadowing seizures. Yet these problems often go unrecognized and, even when identified, are often undertreated or untreated.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15186343     DOI: 10.1111/j.0013-9580.2004.452003.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  17 in total

Review 1.  Hippocampal neurogenesis and neural stem cells in temporal lobe epilepsy.

Authors:  Ramkumar Kuruba; Bharathi Hattiangady; Ashok K Shetty
Journal:  Epilepsy Behav       Date:  2008-10-01       Impact factor: 2.937

2.  Neural stem cell grafting in an animal model of chronic temporal lobe epilepsy.

Authors:  Bharathi Hattiangady; Ashok K Shetty
Journal:  Curr Protoc Stem Cell Biol       Date:  2011-09

3.  The Timing, Nature, and Range of Neurobehavioral Comorbidities in Juvenile Myoclonic Epilepsy.

Authors:  Dace N Almane; Jana E Jones; Taylor McMillan; Carl E Stafstrom; David A Hsu; Michael Seidenberg; Bruce P Hermann; Temitayo O Oyegbile
Journal:  Pediatr Neurol       Date:  2019-03-19       Impact factor: 3.372

4.  Self-Esteem, Social Phobia and Depression Status in Patients with Epilepsy.

Authors:  Ayşe Kutlu; Gökçen Gökçe; Ülkü Büyükburgaz; Macit Selekler; Sezer KOMŞUOğLU
Journal:  Noro Psikiyatr Ars       Date:  2013-12-01       Impact factor: 1.339

5.  Anxiogenic-like profile of Wistar adult rats based on the pilocarpine model: an animal model for trait anxiety?

Authors:  Filipe S Duarte; Marcelo Duzzioni; Alexandre A Hoeller; Nayana M Silva; Andy L Ern; Tetsade C Piermartiri; Carla I Tasca; Elaine C Gavioli; Tadeu Lemos; Antonio P Carobrez; Thereza C M De Lima
Journal:  Psychopharmacology (Berl)       Date:  2012-12-29       Impact factor: 4.530

Review 6.  Turning down the volume: Astrocyte volume change in the generation and termination of epileptic seizures.

Authors:  Thomas R Murphy; Devin K Binder; Todd A Fiacco
Journal:  Neurobiol Dis       Date:  2017-04-22       Impact factor: 5.996

7.  Epilepsy and the plastic mind.

Authors:  Janice Naegele
Journal:  Epilepsy Curr       Date:  2009 Nov-Dec       Impact factor: 7.500

8.  Grafting of striatal precursor cells into hippocampus shortly after status epilepticus restrains chronic temporal lobe epilepsy.

Authors:  Bharathi Hattiangady; Muddanna S Rao; Ashok K Shetty
Journal:  Exp Neurol       Date:  2008-05-15       Impact factor: 5.330

Review 9.  Implications of decreased hippocampal neurogenesis in chronic temporal lobe epilepsy.

Authors:  Bharathi Hattiangady; Ashok K Shetty
Journal:  Epilepsia       Date:  2008-06       Impact factor: 5.864

Review 10.  Stabilizing dendritic structure as a novel therapeutic approach for epilepsy.

Authors:  Michael Wong
Journal:  Expert Rev Neurother       Date:  2008-06       Impact factor: 4.618

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.